Quarterly report pursuant to Section 13 or 15(d)

Note 7 - Concentration of Credit Risk

v3.7.0.1
Note 7 - Concentration of Credit Risk
6 Months Ended
Jun. 30, 2017
Notes to Financial Statements  
Concentration Risk Disclosure [Text Block]
NOTE
7
CONCENTRATION OF CREDIT RISK
 
Milestone Scientific's consolidated financial instruments that are exposed to concentrations of credit risk consist primarily of cash, trade accounts receivable, and advances on contracts. Milestone Scientific places its cash and cash equivalents with large financial institutions. At times, such investments
may
be in excess of the Federal Deposit Insurance Corporation insurance limit. Milestone Scientific has
not
experienced any losses in such accounts and believes it is
not
exposed to any significant credit risks. Financial instruments which potentially subject Milestone Scientific to credit risk consist principally of trade accounts receivable, as Milestone Scientific does
not
require collateral or other security to support customer receivables, and advances on contracts.
 
 
Milestone Scientific closely monitors the extension of credit to its customers while maintaining allowances, if necessary, for potential credit losses. On a periodic basis, Milestone Scientific evaluates its accounts receivable and establishes an allowance for doubtful accounts, based on a history of past write-offs and collections and current credit conditions.